|
Management Comments
“Total revenue in the third quarter was largely consistent with the prior-year period,” said Moshik Itzkovich, Chief Financial Officer of InMode. “Both U.S. and international capital equipment revenue remained relatively stable compared to the second quarter of 2026. These results are consistent with the stabilization we expect to continue through the remainder of the year. We remain focused on disciplined execution and investing in opportunities that support long-term growth.”
Third Quarter 2026 Financial Results
Total GAAP revenues for the third quarter of 2026 were $92.1 million, broadly in line with the $93.2 million reported in the prior-year period. Revenues in Asia continued to grow strongly and reached another quarterly record, reflecting sustained demand across key markets in the region. Quarterly revenues from consumables and service decreased 3% to $19.3 million, compared to the third quarter of 2025.
GAAP gross margin for the third quarter of 2026 was 78%, compared to 78% for the third quarter of 2025. *Non-GAAP gross margin for the third quarter of 2026 was 78%, compared to 78% for the third quarter of 2025. Gross margin for the third quarter of 2026 benefited from a non-recurring U.S. tariff refund, which increased gross margin by approximately one percentage point.
GAAP operating margin for the third quarter of 2026 was 19%, compared to 22% for the third quarter of 2025. *Non-GAAP operating margin for the third quarter of 2026 was 22%, compared to 25% for the third quarter of 2025. These decreases were primarily attributable to the restructuring of the North American sales team implemented toward the end of 2025, increased sales and marketing investments to retain talent and maintain market share, and higher general and administrative expenses driven by increased professional services costs. These factors are expected to continue to affect expenses for the foreseeable future.
InMode reported GAAP net income of $18.9 million, or $0.32 per diluted share, in the third quarter of 2026, compared to $21.9 million, or $0.34 per diluted share, in the third quarter of 2025. On a *non-GAAP basis, InMode reported net income of $21.9 million, or $0.37 per diluted share, in the third quarter of 2026, compared to $24.5 million, or $0.38 per diluted share, in the third quarter of 2025.
As of September 30, 2026, InMode had cash and cash equivalents, marketable securities and short-term bank deposits of $512.7 million.
2026 Financial Outlook
Management reaffirmed its previously issued financial outlook for the full fiscal year ending December 31, 2026. Based on current estimates, management expects:
- Revenues between $365 million and $375 million
- *Non-GAAP gross margin between 74% and 76%
- *Non-GAAP income from operations between $68 million and $73 million
- *Non-GAAP earnings per diluted share between $1.29 and $1.34
These expectations are based on management’s current estimates and are subject to change.
This outlook is not a guarantee of future performance, and investors should not place undue reliance on these forward-looking statements. See “Forward-Looking Statements” for additional information.
*Please refer to “Use of non-GAAP Financial Measures” below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements included in this release. Non-GAAP results exclude share-based compensation, expenses related to the Special Committee’s review (representing non-recurring cost) and related income tax adjustments where applicable.
Investor Relations Update
The Special Committee has completed its work and ceased its activities. The Company will resume its investor relations activities, including participation in investor conferences and engagement with research analysts and investors. In addition, the Company plans to host an earnings conference call in connection with the release of its Q4 and full-year 2026 financial results early next year.
The Current Situation in Israel
The scope and severity of ongoing conflicts in Gaza, northern Israel, Lebanon, Iran, and the broader region are unpredictable and could escalate at any time. To date, our operations have not been materially affected. We continue to closely monitor political and military developments and to assess their potential consequences for our operations and assets.
Use of Non-GAAP Financial Measures
In addition to InMode’s operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, non-GAAP operating margin, non-GAAP gross margin and non-GAAP income from operations. Because these measures are used in InMode’s internal analysis of financial and operating performance, management believes they provide investors with greater transparency into its view of InMode’s economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode’s GAAP operating results, allows investors to more effectively evaluate and compare InMode’s performance to that of its peers, although InMode’s presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release. Reconciliations of non-GAAP gross margin, non-GAAP income from operations, and non-GAAP earnings per diluted share for management’s projections of such non-GAAP financial measures for the 2026 fiscal year are not available without unreasonable effort due to the variability, complexity and limited visibility of certain reconciling items, including share-based compensation, expenses related to the Special Committee review and related income tax adjustments where applicable. These reconciling items could have a significant and unpredictable impact on our future GAAP results.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency (“RF”) technology. InMode strives to enable emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.
Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. These statements generally relate to future events or InMode’s future financial or operating performance, including statements regarding InMode’s 2026 financial outlook, expected expense trends, anticipated demand for its products, including Morpheus8 Max, and the Special Committee’s evaluation of unsolicited proposals. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “would” and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management’s current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode’s Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.
| 
